Supplemental material
Gynecological Endocrinology
Volume 35, 2019 - Issue 5
ESTROGEN AND ENDOMETRIAL CARCINOGENESIS
Two-sided role of estrogen on endometrial carcinogenesis: stimulator or suppressor?
Tsutomu MiyamotoDepartment of Obstetrics and Gynecology, Shinshu University School of Medicine, Matsumoto, JapanCorrespondence[email protected]
http://orcid.org/0000-0002-1513-9473
http://orcid.org/0000-0002-1513-9473 & Related Research Data
Serum estrogens and androgens in women with endometrial carcinoma
Source:
Elsevier BV
Risk Factors for Young Premenopausal Women With Endometrial Cancer
Source:
Ovid Technologies (Wolters Kluwer Health)
Circulating Estrogens in Endometrial Cancer Cases and Their Relationship with Tissular Expression of Key Estrogen Biosynthesis and Metabolic Pathways
Source:
The Endocrine Society
Genotoxicity of the steroidal oestrogens oestrone and oestradiol: possible mechanism of uterine and mammary cancer development
Source:
Oxford University Press (OUP)
Case-control study of endogenous steroid hormones and endometrial cancer.
Source:
Oxford University Press (OUP)
International Patterns and Trends in Endometrial Cancer Incidence, 1978–2013
Source:
Oxford University Press (OUP)
Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin
Source:
Elsevier BV
Polycystic ovary syndrome and cancer
Source:
Oxford University Press (OUP)
hMLH1 promoter hypermethylation and MSI status in human endometrial carcinomas with and without metastases
Source:
Springer Nature
Two pathogenetic types of endometrial carcinoma
Source:
Elsevier BV
Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition
Source:
Bioscientifica
β- And γ-catenin expression in endometrial carcinoma. Relationship with clinicopathological features and microsatellite instability
Source:
Springer Nature
Akt-Mediated Phosphorylation and Activation of Estrogen Receptor α Is Required for Endometrial Neoplastic Transformation in Pten +/− Mice
Source:
American Association for Cancer Research (AACR)
Endometrial Tumorigenesis in Pten+/− Mice Is Independent of Coexistence of Estrogen and Estrogen Receptor α
Source:
Elsevier BV
Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women
Source:
Elsevier BV
Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study
Source:
Springer Nature
Milestones of Lynch syndrome: 1895-2015
Source:
Springer Science and Business Media LLC
Measurement of a Comprehensive Sex Steroid Profile in Rodent Serum by High-Sensitive Gas Chromatography-Tandem Mass Spectrometry
Source:
The Endocrine Society
Chronological observation of mouse endometrial carcinogenesis induced by N-methyl-N-nitrosourea and 17β-estradiol
Source:
Elsevier BV
Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers
Source:
Springer Nature
Elevated Serum Levels of Estradiol Induce Endometrial Hyperplasia Rather than Carcinoma in a Mouse Model Using a Carcinogen
Source:
OMICS Publishing Group
Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia
Source:
Elsevier BV
Polycystic Ovary Syndrome and Endometrial Cancer
Source:
Georg Thieme Verlag KG
Two-sided role of estrogen on endometrial carcinogenesis: stimulator or suppressor?
Source:
Taylor & Francis
Elevated Serum Level of Anti-Mullerian Hormone in Patients with Polycystic Ovary Syndrome: Relationship to the Ovarian Follicle Excess and to the Follicular Arrest
Source:
The Endocrine Society
Endometrial Carcinomas in Women Aged 40 Years and Younger: Tumors Associated With Loss of DNA Mismatch Repair Proteins Comprise a Distinct Clinicopathologic Subset
Source:
Ovid Technologies (Wolters Kluwer Health)
Integrated genomic characterization of endometrial carcinoma
Source:
Springer Nature
Estrogen Up-Regulates Mismatch Repair Activity in Normal and Malignant Endometrial Glandular Cells
Source:
The Endocrine Society
Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease
Source:
Proceedings of the National Academy of Sciences
Linking provided by
